Company news

iBio, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

iBio Provides Update on IBIO-201 COVID-19 Vaccine Program

August 9, 2020

iBio Announces Second COVID-19 Vaccine Program

June 3, 2020

iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™

April 26, 2020

iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute

April 8, 2020

iBio Announces Advancement of COVID-19 Vaccine Program

March 25, 2020

iBio Joins the Alliance for Biosecurity

March 19, 2020

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

March 17, 2020

iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO

March 11, 2020

iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split

March 1, 2020

iBio, Inc. Announces Postponement of Annual Meeting

February 5, 2020

iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance

January 15, 2020

iBio Initiates New Litigation Against Fraunhofer

January 5, 2020

iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing

December 22, 2019

iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan

December 12, 2019

iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production

December 9, 2019

iBio Joins Manufacturing USA’s Tissue Biofabrication Initiative

December 2, 2019

← Newer news releases

Decks

The 5 newest of 20 decks. Every deck is listed under its year.